This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barnes PJ, Celli BR . Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165–1185.
Hogg JC . Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2001; 164: S71–S75.
Weile J, Streeck B, Muck J, Krebs G, Jakobus KH, Knabbe C et al. Severe cytomegalovirus-associated esophagitis in an immunocompetent patient after short-term steroid therapy. J Clin Microbiol 2009; 47: 3031–3033.
Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE . Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 2011; 6: e16103.
Lambers C, Hacker S, Posch M, Hoetzenecker K, Pollreisz A, Lichtenauer M et al. T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2009; 155: 466–475.
Hodge G, Mukaro V, Reynolds PN, Hodge S . Role of increased CD8/CD28null T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease. Clin Exp Immunol 2011; 166: 94–102.
Moro-Garcia MA, Alonso-Arias R, Lopez-Larrea C . Molecular mechanisms involved in the aging of the T-cell immune response. Curr Genomics 2012; 13: 589–602.
Tan DB, Fernandez S, Price P, French MA, Thompson PJ, Moodley YP . Impaired CTLA-4 responses in COPD are associated with systemic inflammation. Cell Mol Immunol 2014; 11: 606–608.
Brunt SJ, Lee S, D'Orsogna L, Bundell C, Burrows S, Price P . The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation. Dis Markers 2014; 2014: 8.
Hummel M and Abecassis MM . A model for reactivation of CMV from latency. J Clin Virol 2002; 25 Suppl 2: S123–S136.
Thewissen M, Somers V, Hellings N, Fraussen J, Damoiseaux J, Stinissen P . CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. J Immunol 2007; 179: 6514–6523.
Acknowledgements
This work was supported by an Ada Bartholomew Grant from The University of Western Australia and a MRF Young Investigator Grant from Royal Perth Hospital. The authors would like to thank the staff at the Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research and the COPD Linkage clinic, Royal Perth Hospital for patient recruitment, and the patients and controls who volunteered for this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tan, D., Amran, F., Teo, TH. et al. Levels of CMV-reactive antibodies correlate with the induction of CD28null T cells and systemic inflammation in chronic obstructive pulmonary disease (COPD). Cell Mol Immunol 13, 551–553 (2016). https://doi.org/10.1038/cmi.2015.4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2015.4
This article is cited by
-
A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17Â T cell production
Medical Microbiology and Immunology (2023)
-
Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients
Respiratory Research (2020)
-
Characterization of CD28null T cells in idiopathic pulmonary fibrosis
Mucosal Immunology (2019)
-
Role of microbiota on lung homeostasis and diseases
Science China Life Sciences (2017)